Three-Dimensional Collagen I Promotes Gemcitabine Resistance In Vitro in Pancreatic Cancer Cells through HMGA2-Dependent Histone Acetyltransferase Expression

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Dangi Garimella, Surabhi ^a   Sahai, Vaibhav ^a   Ebine, Kazumi ^a   Kumar, Krishan ^a   Munshi, Hidayatullah G ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; E1A ASSOCIATED P300 PROTEIN; GEMCITABINE; HIGH MOBILITY GROUP A2 PROTEIN; HISTONE ACETYLTRANSFERASE; HISTONE ACETYLTRANSFERASE GCN5; HISTONE ACETYLTRANSFERASE PCAF; HISTONE H3; HISTONE H3K27; HISTONE H3K9; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER RESISTANCE; CONTROLLED STUDY; CYSTIC FIBROSIS; DOWN REGULATION; HISTONE ACETYLATION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; PANCREAS ADENOCARCINOMA; PROTEIN EXPRESSION; TUMOR MICROENVIRONMENT;

CELL LINE, TUMOR; COLLAGEN TYPE I; DEOXYCYTIDINE; DRUG RESISTANCE, NEOPLASM; HISTONE ACETYLTRANSFERASES; HMGA2 PROTEIN; HUMANS; P300-CBP TRANSCRIPTION FACTORS; PANCREATIC NEOPLASMS;

EID: 84877828072     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064566     Document Type: Article

References (51)

1. Vincent A, Herman J, Schulick R, Hruban RH, Goggins M, (2011) Pancreatic cancer. Lancet 378: 607-620.
2. Hidalgo M, (2010) Pancreatic cancer. N Engl J Med 362: 1605-1617.
3. Jemal A, Bray F, (2011) Center MM, Ferlay J, Ward E, et al (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
4. Shields MA, Dangi-Garimella S, Redig AJ, Munshi HG, (2012) Biochemical role of the collagen-rich tumor microenvironment in pancreatic cancer progression. Biochem J 441: 541-552.
5. Ottaviano AJ, Sun L, Ananthanarayanan V, Munshi HG, (2006) Extracellular matrix-mediated membrane-type 1 matrix metalloproteinase expression in pancreatic ductal cells is regulated by transforming growth factor-beta1. Cancer Res 66: 7032-7040.
6. Dangi-Garimella S, Krantz SB, Barron MR, Shields MA, Heiferman MJ, et al. (2011) Three-Dimensional Collagen I Promotes Gemcitabine Resistance in Pancreatic Cancer through MT1-MMP-Mediated Expression of HMGA2. Cancer Res 71: 1019-1028.
7. Olive KP, Jacobetz MA, Davidson CJ, Gopinathan A, McIntyre D, et al. (2009) Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 324: 1457-1461.
8. Provenzano PP, Cuevas C, Chang AE, Goel VK, Von Hoff DD, et al. (2012) Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma. Cancer Cell 21: 418-429.
9. Jacobetz MA, Chan DS, Neesse A, Bapiro TE, Cook N, et al. (2012) Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer. Gut.
10. Pfannkuche K, Summer H, Li O, Hescheler J, Droge P, (2009) The high mobility group protein HMGA2: a co-regulator of chromatin structure and pluripotency in stem cells? Stem Cell Rev 5: 224-230.
11. Fusco A, Fedele M, (2007) Roles of HMGA proteins in cancer. Nat Rev Cancer 7: 899-910.
12. Hristov AC, Cope L, Reyes MD, Singh M, Iacobuzio-Donahue C, et al. (2009) HMGA2 protein expression correlates with lymph node metastasis and increased tumor grade in pancreatic ductal adenocarcinoma. Mod Pathol 22: 43-49.
13. Piscuoglio S, Zlobec I, Pallante P, Sepe R, Esposito F, et al. (2012) HMGA1 and HMGA2 protein expression correlates with advanced tumour grade and lymph node metastasis in pancreatic adenocarcinoma. Histopathology 60: 397-404.
14. Wei Y, Xia W, Zhang Z, Liu J, Wang H, et al. (2008) Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers. Mol Carcinog 47: 701-706.
15. Manuyakorn A, Paulus R, Farrell J, Dawson NA, Tze S, et al. (2010) Cellular histone modification patterns predict prognosis and treatment response in resectable pancreatic adenocarcinoma: results from RTOG 9704. J Clin Oncol 28: 1358-1365.
16. Bernstein BE, Meissner A, Lander ES, (2007) The mammalian epigenome. Cell 128: 669-681.
17. Esteller M, (2007) Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 8: 286-298.
18. Ellis L, Atadja PW, Johnstone RW, (2009) Epigenetics in cancer: targeting chromatin modifications. Mol Cancer Ther 8: 1409-1420.
19. Keppler BR, Archer TK, (2008) Chromatin-modifying enzymes as therapeutic targets - Part 2. Expert Opin Ther Targets 12: 1457-1467.
20. Keppler BR, Archer TK, (2008) Chromatin-modifying enzymes as therapeutic targets - Part 1. Expert Opin Ther Targets 12: 1301-1312.
21. Schneider G, Kramer OH, Schmid RM, Saur D, (2011) Acetylation as a transcriptional control mechanism-HDACs and HATs in pancreatic ductal adenocarcinoma. J Gastrointest Cancer 42: 85-92.
22. Dekker FJ, Haisma HJ, (2009) Histone acetyl transferases as emerging drug targets. Drug Discov Today 14: 942-948.
23. Koenig A, Linhart T, Schlengemann K, Reutlinger K, Wegele J, et al. (2010) NFAT-induced histone acetylation relay switch promotes c-Myc-dependent growth in pancreatic cancer cells. Gastroenterology 138: 1189-1199 e1181-1182.
24. Bandyopadhyay D, Okan NA, Bales E, Nascimento L, Cole PA, et al. (2002) Down-regulation of p300/CBP histone acetyltransferase activates a senescence checkpoint in human melanocytes. Cancer Res 62: 6231-6239.
25. Jin Q, Yu LR, Wang L, Zhang Z, Kasper LH, et al. (2011) Distinct roles of GCN5/PCAF-mediated H3K9ac and CBP/p300-mediated H3K18/27ac in nuclear receptor transactivation. EMBO J 30: 249-262.
26. Knoepfler PS, Zhang XY, Cheng PF, Gafken PR, McMahon SB, et al. (2006) Myc influences global chromatin structure. EMBO J 25: 2723-2734.
27. Ogiwara H, Ui A, Otsuka A, Satoh H, Yokomi I, et al. (2011) Histone acetylation by CBP and p300 at double-strand break sites facilitates SWI/SNF chromatin remodeling and the recruitment of non-homologous end joining factors. Oncogene 30: 2135-2146.
28. Guo R, Chen J, Mitchell DL, Johnson DG, (2011) GCN5 and E2F1 stimulate nucleotide excision repair by promoting H3K9 acetylation at sites of damage. Nucleic Acids Res 39: 1390-1397.
29. Chu GC, Kimmelman AC, Hezel AF, DePinho RA, (2007) Stromal biology of pancreatic cancer. J Cell Biochem 101: 887-907.
30. Palmieri D, Valentino T, D'Angelo D, De Martino I, Postiglione I, et al. (2011) HMGA proteins promote ATM expression and enhance cancer cell resistance to genotoxic agents. Oncogene 30: 3024-3035.
31. Zha L, Wang Z, Tang W, Zhang N, Liao G, et al. (2012) Genome-wide analysis of HMGA2 transcription factor binding sites by ChIP on chip in gastric carcinoma cells. Mol Cell Biochem 364: 243-251.
32. Li AY, Lin HH, Kuo CY, Shih HM, Wang CC, et al. (2011) High-mobility group A2 protein modulates hTERT transcription to promote tumorigenesis. Mol Cell Biol 31: 2605-2617.
33. Yu KR, Park SB, Jung JW, Seo MS, Hong IS, et al. (2013) HMGA2 regulates the in vitro aging and proliferation of human umbilical cord blood-derived stromal cells through the mTOR/p70S6K signaling pathway. Stem Cell Res 10: 156-165.
34. Miyake K, Yoshizumi T, Imura S, Sugimoto K, Batmunkh E, et al. (2008) Expression of hypoxia-inducible factor-1alpha, histone deacetylase 1, and metastasis-associated protein 1 in pancreatic carcinoma: correlation with poor prognosis with possible regulation. Pancreas 36: e1-9.
35. Ouaissi M, Sielezneff I, Silvestre R, Sastre B, Bernard JP, et al. (2008) High histone deacetylase 7 (HDAC7) expression is significantly associated with adenocarcinomas of the pancreas. Ann Surg Oncol 15: 2318-2328.
36. Wang G, He J, Zhao J, Yun W, Xie C,et al. Class I and class II histone deacetylases are potential therapeutic targets for treating pancreatic cancer. PLoS One 7: e52095.
37. Storch K, Eke I, Borgmann K, Krause M, Richter C, et al. (2010) Three-dimensional cell growth confers radioresistance by chromatin density modification. Cancer Res 70: 3925-3934.
38. Harris CC, Connor RJ, Jackson FE, Lieberman MW, (1974) Intranuclear distribution of DNA repair synthesis induced by chemical carcinogens or ultraviolet light in human diploid fibroblasts. Cancer Res 34: 3461-3468.
39. Murga M, Jaco I, Fan Y, Soria R, Martinez-Pastor B, et al. (2007) Global chromatin compaction limits the strength of the DNA damage response. J Cell Biol 178: 1101-1108.
40. Wagner JM, Hackanson B, Lubbert M, Jung M, (2010) Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy. Clin Epigenetics 1: 117-136.
41. Ouaissi M, Giger U, Sielezneff I, Pirro N, Sastre B, et al. (2011) Rationale for possible targeting of histone deacetylase signaling in cancer diseases with a special reference to pancreatic cancer. J Biomed Biotechnol 2011: 315939.
42. Baylin SB, Jones PA, (2011) A decade of exploring the cancer epigenome - biological and translational implications. Nat Rev Cancer 11: 726-734.
43. Richards DA, Boehm KA, Waterhouse DM, Wagener DJ, Krishnamurthi SS, et al. (2006) Gemcitabine plus CI-994 offers no advantage over gemcitabine alone in the treatment of patients with advanced pancreatic cancer: results of a phase II randomized, double-blind, placebo-controlled, multicenter study. Ann Oncol 17: 1096-1102.
44. Eliseeva ED, Valkov V, Jung M, Jung MO, (2007) Characterization of novel inhibitors of histone acetyltransferases. Mol Cancer Ther 6: 2391-2398.
45. Bowers EM, Yan G, Mukherjee C, Orry A, Wang L, et al. (2010) Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor. Chem Biol 17: 471-482.
46. Santer FR, Hoschele PP, Oh SJ, Erb HH, Bouchal J, et al. (2011) Inhibition of the acetyltransferases p300 and CBP reveals a targetable function for p300 in the survival and invasion pathways of prostate cancer cell lines. Mol Cancer Ther 10: 1644-1655.
47. Dangi-Garimella S, Redig AJ, Shields MA, Siddiqui MA, Munshi HG, (2010) Rho-ROCK-myosin signaling mediates membrane type 1 matrix metalloproteinase-induced cellular aggregation of keratinocytes. J Biol Chem 285: 28363-28372.
48. Shields MA, Dangi-Garimella S, Krantz SB, Bentrem DJ, Munshi HG, (2011) Pancreatic Cancer Cells Respond to Type I Collagen by Inducing Snail Expression to Promote Membrane Type 1 Matrix Metalloproteinase-dependent Collagen Invasion. J Biol Chem 286: 10495-10504.
49. Shields MA, Krantz SB, Bentrem DJ, Dangi-Garimella S, Munshi HG, (2012) Interplay between beta1-Integrin and Rho Signaling Regulates Differential Scattering and Motility of Pancreatic Cancer Cells by Snail and Slug Proteins. J Biol Chem 287: 6218-6229.
50. Munshi HG, Wu YI, Mukhopadhyay S, Ottaviano AJ, Sassano A, et al. (2004) Differential regulation of membrane type 1-matrix metalloproteinase activity by ERK 1/2- and p38 MAPK-modulated tissue inhibitor of metalloproteinases 2 expression controls transforming growth factor-beta1-induced pericellular collagenolysis. J Biol Chem 279: 39042-39050.
51. Dangi-Garimella S, Strouch MJ, Grippo PJ, Bentrem DJ, Munshi HG, (2011) Collagen regulation of let-7 in pancreatic cancer involves TGF-beta1-mediated membrane type 1-matrix metalloproteinase expression. Oncogene 30: 1002-1008.